GYRE icon

Gyre Therapeutics
GYRE

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $15.6M invested in Gyre Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

48% less funds holding

Funds holding: 31 → 16 (-15)

83% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 18

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.23M
Puts
$514K
Net Calls
Net Calls Change

Top Buyers

1
+$4.73M
2
+$4.42M
3
+$3.01M
4
Northern Trust
Northern Trust
Illinois
+$484K
5
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$436K

Top Sellers

1
-$573K
2
-$47.1K
3
-$43.4K
4
NCM
Nantahala Capital Management
Connecticut
-$32.7K
5
JJ
Johnson & Johnson
New Jersey
-$32.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
1
2